Rectal ulcer in a hemodialysis patient receiving Kayexalate®

Julia Collot; Tayeb Salaouatchi; Fabienne Rickaert; Albino Floriani; Benoit Buysschaert; Maria Mesquita; Eric Godon

doi:10.1002/ccr3.4043

Rectal ulcer in a hemodialysis patient receiving Kayexalate^®

Clin Case Rep. 2021 Mar 13;9(4):2385-2389. doi: 10.1002/ccr3.4043. eCollection 2021 Apr.

Authors

Julia Collot¹, Tayeb Salaouatchi², Fabienne Rickaert³, Albino Floriani⁴, Benoit Buysschaert¹, Maria Mesquita², Eric Godon⁵

Affiliations

¹ Nephrology and Dialysis Clinic Centre Hospitalier Regional de Huy Huy Belgium.
² Nephrology and Dialysis Clinic Internal Medicine Department Centre Hospitalier Universitaire CHU-Brugmann Brussels Belgium.
³ Department of Pathology Centre Hospitalier Universitaire Liège Belgium.
⁴ Department of Gastroenterology Centre Hospitalier Regional de Huy Huy Belgium.
⁵ Centre Hospitalier Regional de Huy Huy Belgium.

Abstract

Kayexalate can cause severe unrecognized GI lesions. Diagnosis of kayexalate crystals in GI biopsy samples is important. Pathologists and clinicians should work hand in hand. New drugs should be available to all patients to treat hyperkalemia.

Keywords: hemodialysis; hyperkalemia; kayexalate crystals; kayexalate®; rectal ulcer.

Publication types

Case Reports